These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. High order W02-reactive stable oligomers of amyloid-β are produced in vivo and in vitro via dialysis and filtration of synthetic amyloid-β monomer. Robb E; Perez K; Hung LW; Masters CL; Barnham KJ; Cherny RA; Bush AI; Adlard PA; Finkelstein DI J Alzheimers Dis; 2015; 44(1):69-78. PubMed ID: 25182735 [TBL] [Abstract][Full Text] [Related]
8. Cellular and molecular biology of Alzheimer's disease and animal models. Price DL; Sisodia SS Annu Rev Med; 1994; 45():435-46. PubMed ID: 8198393 [TBL] [Abstract][Full Text] [Related]
9. Low-n oligomers as therapeutic targets of Alzheimer's disease. Ono K; Yamada M J Neurochem; 2011 Apr; 117(1):19-28. PubMed ID: 21244429 [TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 is critical for the propagation of β-amyloid protein and reducing the glycosylation of tau in Alzheimer's disease. Guan PP; Yu X; Zou YH; Wang P Cell Mol Immunol; 2019 Nov; 16(11):892-894. PubMed ID: 31551514 [No Abstract] [Full Text] [Related]
11. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library. Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663 [TBL] [Abstract][Full Text] [Related]
12. Tenascin-C deficiency ameliorates Alzheimer's disease-related pathology in mice. Xie K; Liu Y; Hao W; Walter S; Penke B; Hartmann T; Schachner M; Fassbender K Neurobiol Aging; 2013 Oct; 34(10):2389-98. PubMed ID: 23673309 [TBL] [Abstract][Full Text] [Related]
13. Elucidating the triggers, progression, and effects of Alzheimer's disease. Medeiros R; Chabrier MA; LaFerla FM J Alzheimers Dis; 2013; 33 Suppl 1():S195-210. PubMed ID: 22635105 [TBL] [Abstract][Full Text] [Related]
14. Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer's disease. van Tijn P; Dennissen FJ; Gentier RJ; Hobo B; Hermes D; Steinbusch HW; Van Leeuwen FW; Fischer DF Neurochem Int; 2012 Oct; 61(5):739-48. PubMed ID: 22797007 [TBL] [Abstract][Full Text] [Related]
15. The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization. Hamley IW Chem Rev; 2012 Oct; 112(10):5147-92. PubMed ID: 22813427 [No Abstract] [Full Text] [Related]
16. A potential function for neuronal exosomes: sequestering intracerebral amyloid-β peptide. Yuyama K; Sun H; Usuki S; Sakai S; Hanamatsu H; Mioka T; Kimura N; Okada M; Tahara H; Furukawa J; Fujitani N; Shinohara Y; Igarashi Y FEBS Lett; 2015 Jan; 589(1):84-8. PubMed ID: 25436414 [TBL] [Abstract][Full Text] [Related]
17. Role of amyloid beta-protein in Alzheimer's disease. Liddell M; Owen MJ Lancet; 1992 Oct; 340(8823):851. PubMed ID: 1357270 [No Abstract] [Full Text] [Related]
18. Clinical genetics, IV. Alzheimer's disease: from gene to pathology. Jay G Am J Psychiatry; 1997 Oct; 154(10):1359. PubMed ID: 9326816 [No Abstract] [Full Text] [Related]
19. Systematic evaluation of magnetic resonance imaging and spectroscopy techniques for imaging a transgenic model of Alzheimer's disease (AβPP/PS1). Esteras N; Alquézar C; Bartolomé F; Antequera D; Barrios L; Carro E; Cerdán S; Martín-Requero A J Alzheimers Dis; 2012; 30(2):337-53. PubMed ID: 22406445 [TBL] [Abstract][Full Text] [Related]
20. Concomitant detection of beta-amyloid peptides with N-terminal truncation and different C-terminal endings in cortical plaques from cases with Alzheimer's disease, senile monkeys and triple transgenic mice. Härtig W; Goldhammer S; Bauer U; Wegner F; Wirths O; Bayer TA; Grosche J J Chem Neuroanat; 2010 Sep; 40(1):82-92. PubMed ID: 20347032 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]